metricas
covid
Annals of Hepatology NON-INVASIVE HEMODYNAMIC ASSESSMENT IN CIRRHOSIS: CHILD-PUGH STRATIFICATION AND ...
Journal Information
Vol. 30. Issue S2.
Abstracts of the 2025 Annual Meeting of the ALEH
(September 2025)
Vol. 30. Issue S2.
Abstracts of the 2025 Annual Meeting of the ALEH
(September 2025)
#60
Full text access
NON-INVASIVE HEMODYNAMIC ASSESSMENT IN CIRRHOSIS: CHILD-PUGH STRATIFICATION AND A PLATELET THRESHOLD TO DEFINE THE HYPERDYNAMIC STATE
Visits
139
Martín Elizondo1, Eugenia Ipar2, Romina Rey1, Leandro Cymberknop2, Marcelo Valverde1, Solange Gerona1, Ricardo Armentano2
1 Unidad Bi-Institucional de Enfermedades Hepáticas Complejas (Hospital Militar. Hospital de Clínicas). Programa de Trasplante Hepático. Montevideo. Uruguay.
2 Universidad Tecnológica Nacional. Facultad Regional Buenos Aires. Grupo de Investigación y Desarrollo en Bioingeniería (GIBIO). Buenos Aires. Argentina.
This item has received
Article information
Abstract
Full Text
Download PDF
Statistics
Tables (1)
Tables
Special issue
This article is part of special issue:
Vol. 30. Issue S2

Abstracts of the 2025 Annual Meeting of the ALEH

More info
Introduction and Objectives

Cirrhosis initially presents a hyperdynamic profile—elevated cardiac output (CO), reduced systemic vascular resistance (SVR) and arterial pressure—which may later evolve into low-output cardiocirculatory failure. Impedance cardiography (IC) enables non-invasive quantification of these changes. To integrate them, we developed the unitless Cardiac Haemodynamic Status (CHS) index, defined as √(CO2 + SVR2 + arterial compliance [AC]2), with all parameters standardised prior to calculation. This study aimed to compare CO, SVR, AC and CHS across healthy controls and cirrhotic patients stratified by Child-Pugh class (A/B/C), and to determine whether a platelet threshold lower than the conventional 140 × 103 /µL more accurately identifies the hyperdynamic circulatory phenotype.

Materials and Methods

Cross-sectional study (2023-2025) of 12 controls and 40 β-blocker–free cirrhotics (A 20, B 12, C 8). Each subject underwent IC. Normality was checked (Shapiro–Wilk); groups were compared with Kruskal–Wallis and Holm-adjusted Mann–Whitney tests. All observed platelet counts (40–190 × 103 /µL) were screened; the cut-off with the lowest p and highest Youden index for CHS was validated by bootstrap ROC.

Results

CO, SVR, AC and CHS differed among the four groups (p≤0.006) (Table). Versus controls, C-P A showed higher SVR/CHS but lower CO/AC; C-P B displayed an isolated CO rise; C-P C had higher SVR/CHS (all p<0.04). A platelet threshold of 93 × 103 /µL optimally discriminated hyperdynamism (p=0.006; Cohen d 0.86; AUC 0.82). Patients below this level had higher CO, AC and CHS and lower SVR.

Conclusions

IC identifies three distinct haemodynamic phenotypes across Child-Pugh classes. The CHS index captures these profiles, while a platelet count below 93 × 103 /µL appears to be a useful surrogate of hyperdynamic circulation.

Full Text

Conflict of interest: None

Variable  Controls  Child A  Child B  Child C 
Cardiac output (CO) (L·min)  6.78 ± 1.41  4.76 ± 1.48  8.27 ± 4.10  6.20 ± 3.25  0.006 
Systemic vascular resistance (SVR) (dyn·s·cm-5892 ± 207  1 677 ± 801  1 024 ± 608  1 147 ± 421  0.002 
Arterial compliance (AC) (mL·mmHg-12.69 ± 0.75  1.47 ± 0.52  2.41 ± 0.98  1.97 ± 0.93  0.001 
CHS index  0.93 ± 0.21  1.74 ± 0.81  1.12 ± 0.61  1.21 ± 0.42  0.002 

Download PDF
Article options
Tools